Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Mads Delbo Larsen, Erik L. de Graaf, Myrthe E. Sonneveld, et al.
Science (2020) Vol. 371, Iss. 6532
Open Access | Times Cited: 330

Showing 1-25 of 330 citing articles:

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 520
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 288
SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 277
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
Willianne Hoepel, Hung‐Jen Chen, Chiara E. Geyer, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 596
Open Access | Times Cited: 212
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin, Andrew Jones, Hans-Heinrich Hoffmann, et al.
Nature (2021) Vol. 599, Iss. 7885, pp. 465-470
Open Access | Times Cited: 162
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
Lok-Yin Roy Wong, Stanley Perlman
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 47-56
Open Access | Times Cited: 162
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 160
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Katharina Röltgen, Scott D. Boyd
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1063-1075
Open Access | Times Cited: 128
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Clinical features and prognostic factors in Covid-19: A prospective cohort study
Sanne de Bruin, Lieuwe D. J. Bos, Marian A. van Roon, et al.
EBioMedicine (2021) Vol. 67, pp. 103378-103378
Open Access | Times Cited: 115
Antibody fucosylation predicts disease severity in secondary dengue infection
Stylianos Bournazos, Hoa Thi My Vo, Veasna Duong, et al.
Science (2021) Vol. 372, Iss. 6546, pp. 1102-1105
Open Access | Times Cited: 110
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Saborni Chakraborty, Joseph C. González, Benjamín L. Sievers, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 635
Open Access | Times Cited: 103
The unique properties of IgG4 and its roles in health and disease
Theo Rispens, Maartje G. Huijbers
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 763-778
Open Access | Times Cited: 94
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 81
Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
Salomé S. Pinho, Inês Alves, Joana Gaifem, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 10, pp. 1101-1113
Open Access | Times Cited: 74
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy
Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1244-1255
Closed Access | Times Cited: 43
Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
Andrew Teo, Hao Dong Tan, Thomas Loy, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011223-e1011223
Open Access | Times Cited: 40
Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases
Matae Ahn, Vivian Chih-Wei Chen, Pritisha Rozario, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2144-2159.e22
Open Access | Times Cited: 39
IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy
Sofia Shkunnikova, Anika Mijakovac, Lucija Sironić, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108169-108169
Open Access | Times Cited: 39
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 30
Comprehensive Immunoglobulin G, A, and M glycopeptide profiling for large-scale biomedical research
Bianca D. M. van Tol, Anna M Wasynczuk, Steinar Gijze, et al.
Molecular & Cellular Proteomics (2025), pp. 100928-100928
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top